Sarita, Sofronio Jr., Gocela .
HRN: 14-00-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2025
CEFTRIAXONE 1G (VIAL)
05/10/2025
05/17/2025
IV
2 Grams
Q24
Moderate Tbi
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes